ALLERGAN INC·4

Jan 6, 4:17 PM ET

ALLERGAN INC 4

4 · ALLERGAN INC · Filed Jan 6, 2004

Insider Transaction Report

Form 4
Period: 2004-01-02
Transactions
  • Award

    Phantom Stock Units

    2004-01-02$76.94/sh+122.48$9,42421,253.96 total
    Exercise: $0.00Common Stock (0 underlying)
Footnotes (4)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly portion of annual retainer.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
  • [F4]Includes phantom stock units accrued under the Allergan, Inc. Dividend Reinvestment Plan.

Documents

1 file
  • 4
    ros235.xmlPrimary